We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cyclosporine-induced hemolytic uremic syndrome and hemorrhagic colitis following renal transplantation.
- Authors
Lapointe, Marc; Baillie, G Mark; Shanmuga Bhaskar, S; Richardson, Mary S; Self, Sally E; Baliga, Prabhakar K; Rajagopalan, Pr
- Abstract
Nephrotoxicity remains one of the most common side-effects of cyclosporine in the setting of transplantation. Acute reversible decreases in glomerular filtration rate and chronic irreversible renal damage are the most common manifestations, but hemolytic uremic syndrome and thrombotic thrombocytopenic purpura have been reported. Prognosis of cyclosporine-associated de novo hemolytic uremic syndrome (CyA-HUS) is poor, with nearly half of affected patients losing function in the transplanted kidney. Therapeutic options are limited, but good outcomes have been reported by switching patients from cyclosporine to tacrolimus. We report an unusual presentation of CyA-HUS associated with hemorrhagic colitis following renal transplantation. The patient was successfully managed by switching from cyclosporine to tacrolimus.
- Subjects
CYCLOSPORINE; HEMOLYTIC-uremic syndrome; KIDNEY transplantation
- Publication
Clinical Transplantation, 1999, Vol 13, Issue 6, p526
- ISSN
0902-0063
- Publication type
Article
- DOI
10.1034/j.1399-0012.1999.130614.x